Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Utah for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Utah only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Utah (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Gregory Austad (NPI 1558574087)

Field	Value
Entity Type	Individual
Organization	Gregory Austad
Address	2121 N 1700 W
City	Layton
State	UT
ZIP	84041
Taxonomy	Rheumatology Physician
NPI Enumerated	May 8, 2007

Payer Source	Total Paid
Medicare	$963.9K
Medicaid	$0

Key Findings

This provider is effectively single‑payer in the claims record: total Medicare revenue is $963.9K while Medicaid billing is listed as none, so Medicare accounts for the entirety of reported public‑payer revenue. That concentration implies financial exposure tied to Medicare reimbursement and suggests limited engagement with Medicaid populations or separate non‑Medicaid contracts not captured here.

Revenue is highly concentrated in biologic drug administration: the precomputed top‑3 share is 74.6% of Medicare revenue, driven by J0129 ($299.5K, 30.7%), J0717 ($252.8K, 25.9%), and J1602 ($174.9K, 17.9%). All three codes are specialty biologic injections used in rheumatology, indicating the practice’s principal service line is on‑site administration of high‑cost biologic therapies.

The code mix and ancillary infusion codes point to an infusion/administration model rather than a primarily office‑visit practice. Infliximab billed under J1745 contributes $141.2K (14.5%) and the practice also bills infusion/administration CPTs such as 96365 ($14.1K), 96413 ($12.2K), 96415 ($4.2K), and 96372 ($1.8K), consistent with routine intravenous and injectable therapy delivery and monitoring.

Claims counts and average paid/claim show a mix of high‑volume, low‑unit payments and higher‑unit injections: J0717 reports 63.2K claims at $4 avg paid/claim ($252.8K revenue), while J0129 reports 9.1K claims at $33 avg paid/claim ($299.5K) and J1602 reports 15.9K claims at $11 avg paid/claim ($174.9K). This pattern is consistent with frequent administration of lower‑paid units alongside less frequent higher‑unit biologic doses.

On competitive standing for the top drugs, the provider is a modest national participant rather than a dominant outlier: J0129 ranks #541 of 1221 (56th percentile; typical, unremarkable volume for this code), J0717 ranks #299 of 848 (65th percentile; typical, unremarkable volume for this code), and J1602 ranks #420 of 1041 (60th percentile; typical, unremarkable volume for this code). J1745 is somewhat stronger at the 76th percentile (#328 of 1352) but still characterized as typical volume, indicating regional relevance without clear national leadership.

Face‑to‑face evaluation and management and routine labs are present but secondary to drug revenue: 99214 ($21.2K, 2.2%) and 99213 ($14K, 1.4%) together contribute a small share of Medicare revenue, and lab panels such as 80053 ($4.4K) and 36415 ($3.8K) support ongoing disease monitoring. Visit and lab ranks (for example 99214 at the 74th percentile) suggest steady ambulatory throughput aligned with a therapy‑administration practice rather than a high‑volume primary‑care E&M practice.

The provider has an established billing tenure: NPI enumerated 2007-05-08 (~19 years ago), indicating long‑standing participation in Medicare billing. Combined with the lack of Medicaid billing on file, this profile suggests an experienced rheumatology practice focused on Medicare patients and biologic/infusion services, which may inform payer contracting and network planning decisions.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

30 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	9,080	$30	$299.5K
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	63,200	$1	$252.8K
J1602	Injection, golimumab, 1 mg, for intravenous use	15,900	$10	$174.9K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	5,430	$30	$141.2K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	240	$90	$21.2K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	320	$40	$14.1K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	260	$50	$14K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	100	$130	$12.5K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	140	$90	$12.2K
80053	The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel.	440	$10	$4.4K

Showing 1–10 of 30

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 30 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Utah Distribution

Gregory Austad — 1 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Utah

Full comparison — all codes billed, vs. state median

30 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0717	4	10	57,900	$1	$388K
J0129	2	10	7,880	$30	$287.1K
J1745	3	10	4,400	$30	$137.1K
J1602	2	10	11,950	$10	$127.5K
96413	20	50	100	$90	$13.8K
99214	715	4,080	80	$80	$11.6K
99215	240	1,190	40	$110	$7.5K
99213	386	3,680	60	$50	$6.4K
96365	6	80	90	$40	$5.2K
90662	365	570	40	$70	$4.8K

Showing 1–10 of 30

Related Providers

Other providers that share a Tax Identification Number (TIN) with Gregory Austad, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Tanner Memorial Clinic	UT	Internal Medicine Physician	$0	$8.1M
Justin Mansfield	UT	Internal Medicine Physician	$716.3K	$0
Andrew Coles	UT	Interventional Pain Medicine Physician	$389.6K	$120.9K
Laurence Nelson	UT	Ophthalmology Physician	$367.8K	$0
Michael Martineau	UT	Dermatology Physician	$323.3K	$0
Glen Biddulph	UT	Internal Medicine Physician	$214.4K	$0
Tyler Williams	UT	Internal Medicine Physician	$179.2K	$0
David Stevens	UT	Orthopaedic Surgery Physician	$160.6K	$0
Amandeep Chadha	UT	Nephrology Physician	$158.8K	$0
Hu Ding	UT	Anatomic Pathology & Clinical Pathology Physician	$147.3K	$20

Nearby Providers

Other providers in the same ZIP code as Gregory Austad, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Davis Behavioral Health Inc	UT	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$70.8M
Davis Hospital & Medical Center LP	UT	General Acute Care Hospital	$0	$22.5M
Ihc Health Services, Inc.	UT	General Acute Care Hospital	$0	$11.6M
Layton City Corporation	UT	Land Ambulance	$377.7K	$4.7M
Hillfield Pediatric & Family Dentistry Inc.	UT	General Practice Dentistry	$0	$3.1M
Catalyst Behavior Solutions	UT	Community/Behavioral Health Agency	$0	$2.8M
Silver Lake Healthcare, Inc.	UT	Community Based Hospice Care Agency	$0	$2.4M
Scott Folkman	UT	Pediatric Dentistry	$0	$2M
Discovery House Lt, Inc.	UT	Methadone Clinic	$76.3K	$1.8M
Silver Lake Healthcare, Inc.	UT	Home Health Agency	$0	$1.6M

Gregory Austad — Billing Profile & Reimbursement Data

Sign up for Gregory Austad — Billing Profile & Reimbursement Data policy alerts

Gregory Austad — Billing Profile & Reimbursement Data

Sign up for Gregory Austad — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References